Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1. Flow diagram of study participants and outcomes.

Published byDaniel Hensley Modified over 7 years ago

Similar presentations

Presentation on theme: "Fig. 1. Flow diagram of study participants and outcomes."— Presentation transcript:

1 Fig. 1. Flow diagram of study participants and outcomes.
From: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Nephrol Dial Transplant. 2007;22(7): doi: /ndt/gfm153 Nephrol Dial Transplant | © The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please

2 Fig. 2. Kaplan–Meier survival curves comparing the dialysis and conservative groups (log rank statistic = 13.63, P < 0.001). From: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Nephrol Dial Transplant. 2007;22(7): doi: /ndt/gfm153 Nephrol Dial Transplant | © The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please

3 Fig. 3. Kaplan–Meier survival curves for those with high comorbidity (score = 2), comparing dialysis and conservative groups (log rank statistic <0.001, df 1, P = 0.98). From: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Nephrol Dial Transplant. 2007;22(7): doi: /ndt/gfm153 Nephrol Dial Transplant | © The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please

4 Fig. 4. ( A ) Kaplan–Meier survival curves for those with ischaemic heart disease, comparing the dialysis and conservative groups (log rank statistic 1.46, df 1, P = 0.27). (B) Kaplan–Meier survival curves for those without ischaemic heart disease, comparing the dialysis and conservative groups (log rank statistic 12.78, df 1, P < ). From: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Nephrol Dial Transplant. 2007;22(7): doi: /ndt/gfm153 Nephrol Dial Transplant | © The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please

Download ppt "Fig. 1. Flow diagram of study participants and outcomes."

Similar presentations

Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L.

Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L.
An update on regional variation in cardiovascular mortality within Europe by Jacqueline Müller-Nordhorn, Sylvia Binting, Stephanie Roll, and Stefan N.

An update on regional variation in cardiovascular mortality within Europe by Jacqueline Müller-Nordhorn, Sylvia Binting, Stephanie Roll, and Stefan N.
Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11):779-788 October 17, 2005 © The Author 2005. Published by Oxford University.

Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11): October 17, 2005 © The Author Published by Oxford University.
Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis by Tuula A. Paajanen, Niku K.J. Oksala,

Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis by Tuula A. Paajanen, Niku K.J. Oksala,
From: An open day in the metric space

From: An open day in the metric space
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
From: Global Banking: Recent Developments and Insights from Research*

From: Global Banking: Recent Developments and Insights from Research*
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.

Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
Fig 1 Trends in organ donors in the UK, 2000–10

Fig 1 Trends in organ donors in the UK, 2000–10
Fig. 3. Quantitative analysis of calcification at the aortic root showing the effect of long-term PD administration of PPi in mice . ( A ) Calcification.

Fig. 3. Quantitative analysis of calcification at the aortic root showing the effect of long-term PD administration of PPi in mice . ( A ) Calcification.
Figure 1 Patient flow chart.

Figure 1 Patient flow chart.
Fig. 1. Serum activity of the osteoclast-specific enzyme TRAP-5b and serum levels of RANKL and OPG, key regulators involved in osteoclast differentiation.

Fig. 1. Serum activity of the osteoclast-specific enzyme TRAP-5b and serum levels of RANKL and OPG, key regulators involved in osteoclast differentiation.
FIGURE 1 Bivariate relationship between serum urea levels and serum Hcit levels, according to different nutritional regimens, namely FD, MD and VLPD. From:

FIGURE 1 Bivariate relationship between serum urea levels and serum Hcit levels, according to different nutritional regimens, namely FD, MD and VLPD. From:
Fig. 1 Changes in biochemical assessment of CKD-MBD over time: Cy/+ rats were treated with diet only (CKD CTL), R-568, R-568 + Ca or calcium alone (Ca).

Fig. 1 Changes in biochemical assessment of CKD-MBD over time: Cy/+ rats were treated with diet only (CKD CTL), R-568, R Ca or calcium alone (Ca).
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
FIGURE 1 Flow chart of the study population

FIGURE 1 Flow chart of the study population
Fig. 1 Flow chart of study selection

Fig. 1 Flow chart of study selection

Similar presentations

Ads by Google